Gefapixant, a Novel P2X3 Antagonist, Protects against Post Myocardial Infarction Cardiac Dysfunction and Remodeling Via Suppressing NLRP3 Inflammasome

Full description

Bibliographic Details

Published in:	Current medical science. - Huazhong University of Science and Technology, 2018. - 43(2023), 1 vom: 09. Jan., Seite 58-68
Main Author:	Wei, Yan-zhao (Author)
Other Authors:	Yang, Shuang (Author) Li, Wei (Author) Tang, Yan-hong (Author)
Format:	electronic Article
Language:	English
Published:	2023
ISSN:	2523-899X
External Sources:	lizenzpflichtig